Biotech News Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech News

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: B O Trust who wrote (6296)	8/25/2008 7:18:10 PM
From: B O Trust	of 7143

UMN Pharma begins preparations for the construction of a manufacturing facility for pandemic influenza vaccine. THIS SOLVES Protein Science’s manufacturing capability... Trials in human subjects already ongoing and the "first-in-man" clinical study of a pandemic influenza vaccine manufactured by cell-culture. Also granted orphan drug designation in Japan. August 29, 2006 UMN Pharma obtained the exclusive rights of the development, manufacturing and sales of Protein Sciences Corp´s influenza vaccines in Japan. IF the US government isn’t interested in Protein Science’s work with the H5NI,. or bird flu, the company will make it available to other countries. Why is the U.S. government putting the big money into timeconsuming, outdated egg-based technology? Why isn’t it helping companies with tested cleaner vaccines produce them faster thus forcing them abroad? umnpharma.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next